Dr. Calvin Chao is a seasoned medical executive with strong expertise in oncology, molecular diagnostics, and medical affairs leadership. He joined ArteraAI as Vice President of Medical Science, where he oversees research & development, medical strategy, and integration of AI-enabled biomarker platforms. Prior to Artera, he held leadership roles at Tempus Labs and Genomic Health, guiding global medical affairs for cancer diagnostics and product launches across multiple regions. Dr. Chao combines his clinical and strategic training (MD, MBA) with engineering foundations to bridge the gap between innovation, clinical practice, and business execution.